17 articles for PR Griffin
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor.
The Scripps Research Institute
Small molecule amides as potent ROR-¿ selective modulators.
The Scripps Research Institute
Differential Modulation of Nuclear Receptor LRH-1 through Targeting Buried and Surface Regions of the Binding Pocket.
Emory University School of Medicine
Structure-Activity Relationship and Biological Investigation of SR18292 (
The Scripps Research Institute
Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone.
The Scripps Research Institute
Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists.
The Scripps Research Institute
Identification of potent RORβ modulators: Scaffold variation.
The Scripps Research Institute
Identification of an aminothiazole series of RORβ modulators.
The Scripps Research Institute
Design, synthesis, and evaluation of simple phenol amides as ERRγ agonists.
The Scripps Research Institute
Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted Antidiabetics.
The Scripps Research Institute
NOVEL AMINE-SUBSTITUTED PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS
Jazz Pharmaceuticals Ireland
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
University of Massachusetts
[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Institut De Recherches Servier